IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Botanical and Plant-Derived Drug Industry to Blossom

12:51 PM MST | February 27, 2009 | DEEPTI RAMESH

The global botanical and plant-derived drug market is expected to blossom by 2013, reaching a combined total of $32.9 billion a compound annual growth rate (CAGR) of 11%, according to a new study by BCC Research (Wellesley, MA). That is an increase from $19.5 billion last year, it adds Botanical drugs are those that are FDA approved under the botanical drug pathway; plant-derived drugs are those under a new FDA classification that are botanicals and contain a mixture of plant-derived and synthetic substances, BCC says. The plant-derived drug sector commands the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa